Genefitletics Enters Into a Strategic Partnership with Genique Lifesciences

New Delhi, India, April 08, 2021 –(PR.com)– Genefitletics has entered into a strategic partnership with Genique Lifesciences to provide Genomics & bioinformatics-based preventive healthcare solutions – Curegenic. Genefitletics is a biotech company working on the intersection of genomics, gut microbiome & circadian rhythm to offer Artificial Intelligence driven hyper personalised preventive health recommendations that help users to prevent & reverse the impact of chronic diseases and improve their lives.

Genefitletics’s comprehensive biointelligence solution-Curegenic, decodes health insights and biomarkers of more than 30 chronic diseases using genetic & gut microbiome testing analysis & analyzes the interaction between food & gut microbes to provide customers with data driven personalized health recommendations. The partnership with Genique will help Genefitletics to expand its horizon in international markets & launch new biomarkers that would be able to predict chronic diseases such as diabetes, cardiovascular disease, depression, Alzhimer’s, Parkinson’s, Acid Reflux & Autism.

Genique Lifesciences, is a genomics driven healthcare company based out of Gurgaon. Genique provides solutions in the space of carrier screening, newborn screening, health, wellness, ancestry and nutrition for patients in India. The company supports Indian clients with a variety of NGS library prep kits, analysis, storage and bioinformatics tools. Genique is committed to improving healthcare outcomes by making DNA based insights easily understandable for clinicians and patients.

The company is channel partners with SOPHiA Genetics, a health tech company democratizing Data-Driven Medicine based in Switzerland; Petagene, a bioinformatics software company for data compression and storage based in Cambrige, UK; Pillar Biosciences, a leading next-generation sequencing clinical company based in Massachusetts and Sentieon that develops highly-optimized algorithms for bioinformatics applications based in San Francisco.

Mr. Sushant Kumar, CEO of Genefitletics quotes, “The current disease led model of medicine is far away from helping people prevent & reverse chronic diseases. The focus on antibiotics & surgeries to manage & suppress symptoms have dragged people towards attracting dreaded diseases such as heart stroke, gastrointestinal diseases, obesity & neurodegenerative disorders. Not to mention the price tag & long term collateral damage this outdated model has produced. We are only 1% human & our body has more foreign cells than human cells. What we require is understanding of invisible forces at work inside our body to bring a human biology science led revolution in healthcare. This will uncover a much needed solution to the biggest global epidemic- chronic inflammation. This strategic foray with Genique will enable us to usher a new science that will bring much needed human & gut microbial DNA based preventive healthcare solutions to empower people to overcome & reverse chronic diseases.”

Mr. Abhishek Das, CEO & Co-Founder quotes, “Genomics and individual DNA play a key role in determining dietary and other healthy habits required to optimise the health of people. These tests are game changers for anyone who wants to improve their health outcomes. If you know thyself, then you can shape thyself. Genique is delighted to partner with Genefitlectics to empower more people to take charge of their health with these tests.”